[Form 3] RESMED INC Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

RESMED INC executive Aaron Bloomer, the company’s Chief Financial Officer, filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider of ResMed but does not list any equity holdings or report any buy or sell transactions.

Key Terms

Form 3, beneficial ownership, Chief Financial Officer

3 terms

Form 3 regulatory

"filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Chief Financial Officer financial

"specifically holding the title Chief Financial Officer"

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bloomer Aaron

(Last) (First) (Middle)

RESMED INC.

9001 SPECTRUM CENTER BLVD.

(Street)

SAN DIEGO CALIFORNIA 92123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/04/2026

3. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Michael J. Rider, attorney-in-fact for Mr. Bloomer	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Aaron Bloomer’s Form 3 filing for RESMED INC (RMD) indicate?

The Form 3 filing shows that Aaron Bloomer, ResMed’s Chief Financial Officer, is now an SEC reporting insider. It is an initial ownership statement and, in this case, does not list any specific shares or transactions.

Does the RESMED INC (RMD) Form 3 for Aaron Bloomer show any share purchases or sales?

No, this Form 3 for Aaron Bloomer reports no transactions. The transaction summary shows zero buys, zero sells, and zero derivative exercises, meaning it only establishes insider status without recording trades.

What role does Aaron Bloomer hold at RESMED INC (RMD) in this Form 3?

The filing identifies Aaron Bloomer as an officer of ResMed Inc., specifically holding the title Chief Financial Officer. He is not listed as a director or a ten percent owner in this document.

Are any derivative securities reported in Aaron Bloomer’s Form 3 for RESMED INC (RMD)?

No derivative securities are reported. The derivativeSummary section is empty and derivativeTransactionCount is zero, indicating no options, warrants, or similar instruments are disclosed in this initial statement.

Why is a Form 3 important for RESMED INC (RMD) insiders like the CFO?

Form 3 formally records an insider’s beneficial ownership status when they first become subject to SEC reporting. For ResMed’s CFO, it establishes ongoing disclosure obligations for future trades in company securities.